QIA.DE : Summary for QIAGEN NV EO -,01 - Yahoo Finance

U.S. Markets closed


XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
25.94-0.44 (-1.67%)
At close: 5:35PM CET
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close26.39
Bid0.00 x 48300
Ask0.00 x 51100
Day's Range25.84 - 26.33
52 Week Range17.76 - 27.67
Avg. Volume368,661
Market Cap6.13B
PE Ratio (TTM)51.89
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Better Buy: Opko Health, Inc. vs. Qiagen
    Motley Foolyesterday

    Better Buy: Opko Health, Inc. vs. Qiagen

    Does Opko Health's recent clinical setback hurt it in a head-to-head comparison with Qiagen? Or does it actually help?

  • QIAGEN NV – Value Analysis (XETRA:QIA) : January 19, 2017
    Capital Cube2 days ago

    QIAGEN NV – Value Analysis (XETRA:QIA) : January 19, 2017

    Categories: Europe Value Analsysis Yahoo Finance Click here to see latest analysis Capitalcube gives QIAGEN NV a score of 50. Our analysis is based on comparing QIAGEN NV with the following peers – Orthofix International NV, Sartorius AG Pref, STRATEC Biomedical AG and Quantel SA (OFX-DE, SRT3-DE, SBS-DE and QUA-FR). Investment Outlook QIAGEN NV has a fundamental score of 50 and ... Read more (Read more...)

  • PR Newswire3 days ago

    QIAGEN Announces Details for Completion of Approximately $250 Million Synthetic Share Repurchase

    VENLO, The Netherlands, January 18, 2017 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) (the "Company") today announced details for completion of a synthetic share ...